Metraipolis › archive › dc_d745e097fbc2

Physiologically based pharmacokinetic model of two ALK inhibitors to inform drug and dosing regimens for brain metastasis patients — Europe PMC PMID:42597673

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42597673
DOI
10.3389/fphar.2026.1901617
License (as archived)
solo-consultazione
Archived
2026-10-17T07:18:03.794Z
SHA-256 of the archived text
69fe17ee69b8a2aa2797eb9a06ccbf9b9efd4bb751677bbef96ad0a06731b0bc
Stable URL of this page
https://metraipolis.com/documento/dc_d745e097fbc2

How to cite

Physiologically based pharmacokinetic model of two ALK inhibitors to inform drug and dosing regimens for brain metastasis patients — Europe PMC PMID:42597673 — Europe PMC (en), https://europepmc.org/article/MED/42597673 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d745e097fbc2 (Metraipolis archive dc_d745e097fbc2, sha256 69fe17ee69b8a2aa2797eb9a06ccbf9b9efd4bb751677bbef96ad0a06731b0bc)
BibTeX
@misc{dcd745e097fbc2,
  title = {Physiologically based pharmacokinetic model of two ALK inhibitors to inform drug and dosing regimens for brain metastasis patients — Europe PMC PMID:42597673},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42597673},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d745e097fbc2; sha256 69fe17ee69b8a2aa2797eb9a06ccbf9b9efd4bb751677bbef96ad0a06731b0bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42597673. Agents can read the archived copy with the MCP tool read_document.